1 / 3

Medikabazaar’s gross revenue crossed Rs 1,500 Cr in FY22

B2B medical supply chain platform Medikabazaar scooped up $65 million led by Lighthouse India in April 2022 with a jump of almost 3X in valuation. The operating gross revenue for the Mumbai-based company grew 2.74X to Rs 1,552.53 crore in FY22 from Rs 564.7 crore in FY21.

Entrackr
Download Presentation

Medikabazaar’s gross revenue crossed Rs 1,500 Cr in FY22

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Medikabazaar’s gross revenuecrossedRs1,500 Cr inFY22 B2BmedicalsupplychainplatformMedikabazaarscoopedup$65millionledbyLighthouseIndiainApril2022withajumpofalmost3Xinvaluation.ThefundraisingcameonthebackofitsstrongfinancialgrowthduringFY22whenitscaled2.74Xwhilealsocontrollingexpenseswell. TheoperatinggrossrevenuefortheMumbai-basedMedikabazaargrew2.74XtoRs 1,552.53croreinFY22fromRs564.7croreinFY21,accordingtotheconsolidatedfinancialstatementsfiledwiththeRegistrarofCompanies. Medikabazaar’splatformenableshospitalsandmedicalestablishmentstodiscoversupplies,comparespecificationsandpricesinreal-time.Itincludeshospitaldevices,medicalconsumables,dentaltools,andothers.ThesaleofmedicalsuppliesisthesolesourceofincomefortheVivekTiwariandKetanMalkan-ledcompany. ThecostofprocurementofsupplieswasthelargestcostcenterforMedikabazaar,accountingfor77.5%ofthetotalexpenses.Withthesurgeinscale,thiscostproportionatelyincreased2.64XtoRs1256.85croreinFY22fromRs475.36croreinFY21.

  2. Toexpandtheoperations,thecompanyhiredmoreworkforce,asaresult,employeebenefitcostsjumped2XtoRs75.88croreinFY22.ThisincludesRs20.11croreasESOPexpenseswhichwerenon-cashinnature.Toexpandtheoperations,thecompanyhiredmoreworkforce,asaresult,employeebenefitcostsjumped2XtoRs75.88croreinFY22.ThisincludesRs20.11croreasESOPexpenseswhichwerenon-cashinnature. Thecostofadvertisementsexpanded3.65XtoRs60.25croreduringFY22whiletransportationdistributionanddiscountingchargesexpanded3.19Xand2.95XrespectivelytoRs86.1croreandRs69.1croreinthelastfiscalyear.

  3. ThecompanyaddedanotherRs17.55croreandRs10.2croreagainstlegalprofessionalchargesandinformationtechnologycostswhichpushedthetotalexpenditureofMedikabazaarby2.68XtoRs1621.57croreduringFY22fromRs603.96croreinFY21.ThecompanyaddedanotherRs17.55croreandRs10.2croreagainstlegalprofessionalchargesandinformationtechnologycostswhichpushedthetotalexpenditureofMedikabazaarby2.68XtoRs1621.57croreduringFY22fromRs603.96croreinFY21. Withasurgeof2.74Xinscale,thecompanykeptatightholdonoverallexpenditure,andcorrespondingtothat,itrecordedalossofRs20.8croreduringthelastfiscalyear.DuringFY21,itslossstoodatRs11lakh. Movingtowardstheratios,itsROCEandEBITDAmarginregisteredat-3.21%and-0.62%duringFY22.Ontheunitlevel,MedikabazaarspentRs1.04croretoearnasingleunitofoperatingrevenue. Themedicalsupplies/equipmentsegment,whileundoubtedlyhugeinthecontextofthemarketsizeinIndia,alsoremainsoneofthetoughesttocrackforstartups,requiringdeepinvestmentsintopeopleandstayingontopofadynamicenvironment.EveninMedikabazaar’scase,withnobreakupofsalesavailable,itwouldbenosurpriseifthespikeisonthebackofafewproductsorproductcategorywhereithasmanagedacompetitiveadvantage. Withofferingsacrossamarketplacemodel,marketingandlogisticssolutionsandevenfinancingformedicalinstitutions,MediKabazaarhassetouttobetheOfBusinessofthehealthcarebusiness,andifthefoundershavereaditright,thefirmhasaverygoodchanceofbecomingone.Theirinvestorsareclearlybettingonit. FormoresuchlateststartupnewsandfundingnewsfollowEntrackr.

More Related